4th of August 2024

Case study: >Your< UTI Free Orosticks

An analysis of how our client launched our UTI product under their brand in a CIS market and achieved a #1 position in the market.

In 2020, our client, a substantial pharmaceutical company from a country in the CIS region, launched >Your< UTI Free Sachets*. The market for UTI supplements in their country was still developing and D-mannose products were on a steep rise. Consequently, our client immediately achieved outstanding results.

*>Your< UTI Free Orosticks are an upgraded version of clinically studied >Your< UTI Free Sachets.

the case study.

Download the case study to discover how and why:

"*" indicates required fields

  • our client successfully launched an extensive face-to-face medical detailing campaign
  • in some cases TV ads can prove more efficient than promotion on digital channels
  • our client achieved a no. 1 position in their market

key results.

  • our client was selling at a rate of 60.000 units per month already in the 15th month after launching
  • they achieved the number 1 position in UTI supplements in their market
  • they surpassed a sell-out of 500.000 yearly units

explore further.

Clinical study on >Your< UTI Free Sachets

A clinical study proved our UTI product substantially improves standard drug treatment for UTIs and helps resolve recurrence. The results were presented in a webinar which is available on demand.

>Your< UTI Free Orosticks

A natural solution for UTI prevention or acute use with an outstanding track record of market response. Supported by 2 clinical studies on the finished product.

"*" indicates required fields

"*" indicates required fields

PharmaLinea © 2025